41![FSTG Newsletter Issue 14 A subject group of the RSC FSTG Bursary scheme FSTG Newsletter Issue 14 A subject group of the RSC FSTG Bursary scheme](https://www.pdfsearch.io/img/23a4bd904d013f6f9b9685b83423e5c0.jpg) | Add to Reading ListSource URL: www.formulation.org.ukLanguage: English - Date: 2014-05-15 06:59:53
|
---|
42![February 2012 Issue 12 Formulation Science and Technology Group Newsletter Lea d S tor y He adl ine February 2012 Issue 12 Formulation Science and Technology Group Newsletter Lea d S tor y He adl ine](https://www.pdfsearch.io/img/1a89a6667f0b19791171cd3f96fddf34.jpg) | Add to Reading ListSource URL: www.formulation.org.ukLanguage: English - Date: 2014-05-15 06:59:53
|
---|
43![FSTGNewsletterJuly2011.pub FSTGNewsletterJuly2011.pub](https://www.pdfsearch.io/img/cd545d5488c9e8b8b189302d2bdf4378.jpg) | Add to Reading ListSource URL: www.formulation.org.ukLanguage: English - Date: 2014-05-15 06:59:53
|
---|
44![YAMANOUCHI TO SPIN OFF TWO FORMULATION PLANTS BY THE CORPORATE SEPARATION METHOD Tokyo, Japan – November 4, 2004 – At its board meeting today, Yamanouchi Pharmaceutical Co., Ltd. (president: Toichi Takenaka) approved YAMANOUCHI TO SPIN OFF TWO FORMULATION PLANTS BY THE CORPORATE SEPARATION METHOD Tokyo, Japan – November 4, 2004 – At its board meeting today, Yamanouchi Pharmaceutical Co., Ltd. (president: Toichi Takenaka) approved](https://www.pdfsearch.io/img/1d887c7280e6de6b4f253926522ebae1.jpg) | Add to Reading ListSource URL: www.astellas.comLanguage: English - Date: 2008-12-10 01:08:36
|
---|
45![Research / Health / Pharmaceutical industry / Nursing research / Pharmacy / Pharmacovigilance / Clinical trial / Formulation / Pharmaceutical sciences / Pharmacology / Clinical research Research / Health / Pharmaceutical industry / Nursing research / Pharmacy / Pharmacovigilance / Clinical trial / Formulation / Pharmaceutical sciences / Pharmacology / Clinical research](/pdf-icon.png) | Add to Reading ListSource URL: www.hma.euLanguage: English - Date: 2011-11-04 08:25:18
|
---|
46![Pediatric Dosage Development: Where Are We? Julia C. Pinto, Ph.D. Acting Branch Chief, Division III, Branch VIII Office of New Drug Quality Assessment, CDER, FDA Pediatric Dosage Development: Where Are We? Julia C. Pinto, Ph.D. Acting Branch Chief, Division III, Branch VIII Office of New Drug Quality Assessment, CDER, FDA](https://www.pdfsearch.io/img/c39ec383c731aecaa974d2e2c0ab1408.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English |
---|
47![Testosterone Gel, CIII, Drug Class and Formulation: Testosterone Gel Products Testosterone Gel, CIII, Drug Class and Formulation: Testosterone Gel Products](https://www.pdfsearch.io/img/2a0cd3bcc7c1ad0b5b69ebd5c67740ed.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English |
---|
48![Interpretation of "Identical Medicinal Ingredient" - Questions and Answers Interpretation of "Identical Medicinal Ingredient" - Questions and Answers](https://www.pdfsearch.io/img/68ad047b97462a4e70abc48e290a01dd.jpg) | Add to Reading ListSource URL: hc-sc.gc.caLanguage: English - Date: 2013-07-12 14:25:51
|
---|
49![Orally Dissolving Pullulan Capsules and Films Summary: This innovation has two forms: a hard capsule that dissolves orally and a film that dissolves orally. The capsules can be filled with a drug formulation containing a Orally Dissolving Pullulan Capsules and Films Summary: This innovation has two forms: a hard capsule that dissolves orally and a film that dissolves orally. The capsules can be filled with a drug formulation containing a](https://www.pdfsearch.io/img/bf3f18876ac8ab253fb2af855ddb1fdb.jpg) | Add to Reading ListSource URL: kuic.ku.eduLanguage: English - Date: 2014-01-30 10:26:48
|
---|
50![PHARMACEUTICAL (MANUFACTURING AND FORMULATION) INDUSTRY Parameter Standards Effluent Standards PHARMACEUTICAL (MANUFACTURING AND FORMULATION) INDUSTRY Parameter Standards Effluent Standards](https://www.pdfsearch.io/img/ee12e3c12c9596aad7a821996928801d.jpg) | Add to Reading ListSource URL: www.appcb.ap.nic.inLanguage: English - Date: 2010-11-19 01:40:32
|
---|